Bayer teamed up with Envirotainerto achieve its current global shippingsolution. Shipments using the jointlydeveloped I-box have provided excellent flatline results in the 2° to 8°C range.By Jim Bacon, Director of Global Supply Chain
Bayer Healthcare - Biological Products DivisionIn the comedy Planes, Trains and Automobiles, Steve Martin and John Candy bumbled and cajoled their way across the country. The film’s enough to send shivers down the spine of anyone involved in the pharmaceutical cold chain. Pharmaceutical and biological products also move over land and sea, and through the air, but their journeys are dead serious, and these sensitive, valuable materials must be kept at optimum temperature throughout their travels.The increased pressure to ensure cold chain integrity has made developing and controlling shipping conditions a top priority for pharmaceutical manufacturers, and many are responding with innovative guidelines and solutions. Working closely with in-house quality assurance and validation teams and vendors, Bayer Biological Products was able to develop an all-season containment design, using a “worst case” scenario to ensure that product integrity would hold up even at extreme temperatures. In this article, we’ll discuss the approach we took and what we found to be “best practices.”Vendor partnerships criticalWhen designing a cold-chain solution, it’s important to focus on practicality, which equals ergonomics plus economics. To put it bluntly, the best design is worthless if your company can’t afford to ship it.The key to cold-chain success is selecting a vendor that has handled a wide variety of projects for different customers. Companies whose hands are tied by proprietary agreements can only provide limited benefit. Cultivating a good relationship with the vendor is essential, as the company needs to understand your specific needs and the interplay between your product, its packaging and the shipping environment. It’s also important to find a solution that you will be comfortable with, since changing strategies can be extremely costly.Bayer worked with one design and testing vendor to devise and carry out an effective cold-chain packaging solution. The company helped us create a structured approach to design and execution, and then worked with our Quality Assurance (QA), Validation and Customer Operations staff to complete the process.The result was the following step-wise approach.
Jim Bacon is director of global supply chain for Bayer Healthcare — Biological Products Division. He is responsible for the allocation and movement of all the division’s products, from manufacturing sites to Bayer regional and third-party affiliates worldwide.
Bayer Healthcare - Biological Products DivisionIn the comedy Planes, Trains and Automobiles, Steve Martin and John Candy bumbled and cajoled their way across the country. The film’s enough to send shivers down the spine of anyone involved in the pharmaceutical cold chain. Pharmaceutical and biological products also move over land and sea, and through the air, but their journeys are dead serious, and these sensitive, valuable materials must be kept at optimum temperature throughout their travels.The increased pressure to ensure cold chain integrity has made developing and controlling shipping conditions a top priority for pharmaceutical manufacturers, and many are responding with innovative guidelines and solutions. Working closely with in-house quality assurance and validation teams and vendors, Bayer Biological Products was able to develop an all-season containment design, using a “worst case” scenario to ensure that product integrity would hold up even at extreme temperatures. In this article, we’ll discuss the approach we took and what we found to be “best practices.”Vendor partnerships criticalWhen designing a cold-chain solution, it’s important to focus on practicality, which equals ergonomics plus economics. To put it bluntly, the best design is worthless if your company can’t afford to ship it.The key to cold-chain success is selecting a vendor that has handled a wide variety of projects for different customers. Companies whose hands are tied by proprietary agreements can only provide limited benefit. Cultivating a good relationship with the vendor is essential, as the company needs to understand your specific needs and the interplay between your product, its packaging and the shipping environment. It’s also important to find a solution that you will be comfortable with, since changing strategies can be extremely costly.Bayer worked with one design and testing vendor to devise and carry out an effective cold-chain packaging solution. The company helped us create a structured approach to design and execution, and then worked with our Quality Assurance (QA), Validation and Customer Operations staff to complete the process.The result was the following step-wise approach.
- Establish a test profile based upon shipping requirements, current packaging methods and proposed shipping systems.
- Conduct baseline tests of current and proposed shipping systems with test profile(s) created in step one.
- Analyze and adjust packaging as needed. Create a test protocol for approval.
- Approve protocol and qualify shipping systems.
- Based on final report and approval, implement the system and generate the standard operation procedures (SOP) and training required.
- How well will each solution fit on a standard pallet?
- Is there enough room for the product to make it worth shipping?
- How much product will fit inside each desired size option?
- Is there enough differentiation between size options?
- introduction and purpose
- test duration
- equipment to be used
- where and how the test will be administered
- number of repeat tests
- procedures to be followed and who will execute each procedure
- thermocouple placement
- expected outcome.
- pre-chilling of containers or ambient start (how many, when, who
- staging
- temperature monitor placement
- monitor checklist
- diagram and container sealing details.
Jim Bacon is director of global supply chain for Bayer Healthcare — Biological Products Division. He is responsible for the allocation and movement of all the division’s products, from manufacturing sites to Bayer regional and third-party affiliates worldwide.